These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1687772)

  • 21. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
    Mutafova-Yambolieva V; Staneva-Stoytcheva D
    Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):551-7. PubMed ID: 2906393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of depression by clonidine of the pressor response to alpha 1-adrenoceptor agonists in pithed rats.
    Nomura S; Sunagane N; Uruno T; Kubota K
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):273-86. PubMed ID: 8829767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs.
    Drieu la Rochelle C; Berdeaux A; Richard V; Giudicelli JF
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):904-10. PubMed ID: 1725905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of receptor reserve in the inhibition of alpha-1 adrenoceptor-mediated pressor responses by calcium antagonists in the pithed rat.
    Jim KF; Macia RA; Matthews WD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):89-94. PubMed ID: 3014124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies in the rat on bucindolol, a new antihypertensive agent with beta-adrenoceptor blocking properties.
    Oates HF; Stoker LM; Stokes GS
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):95-102. PubMed ID: 6114719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
    Kubo K; Ikeda J; Nakamura J; Nakamizo N
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat.
    Jie K; van Brummelen P; Timmermans PB; Thoolen MJ; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):72-86. PubMed ID: 2869738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil.
    Sugimoto T; Hosoki K; Karasawa T
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
    Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
    Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular effects and interaction with adrenoceptors of urapidil.
    van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
    Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive and adrenoceptor blocking properties of new sulfonamide-substituted phenylethylamines.
    Takenaka T; Shiono K; Honda K; Asano M; Miyazaki I; Maeno H
    Clin Exp Hypertens A; 1982; 4(1-2):125-37. PubMed ID: 7074981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
    Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats.
    Nakamoto M; Ohya Y; Sakima A; Yamazato M; Takishita S
    Hypertens Res; 2007 Apr; 30(4):359-66. PubMed ID: 17541215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N; Sugawara K; Ozaki M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
    Pedrinelli R; Tarazi RC
    J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.